Cuff v. Florida Board of Pharmacy, Florida Department of Health
In Cuff v. Florida Board of Pharmacy, the court ruled that the Florida Board of Pharmacy exceeded its authority by requiring pharmacists to report certain information to the PDMP that was not mandated by statute. This decision limits the Board's ability to impose additional PDMP reporting requirements beyond those explicitly authorized by law.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 27, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Florida should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately upon review; no specific deadline but non-compliance with invalid rules is no longer required.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The Florida Board of Pharmacy can no longer enforce PDMP reporting requirements that are not explicitly required by Florida statute. Any prior Board rules or guidance imposing additional reporting obligations are invalid.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies in Florida
What you must do
Review current PDMP reporting practices to ensure compliance only with statutory requirements, not any extra Board-imposed rules. Discontinue any voluntary or Board-mandated reporting beyond statutory mandates.
Deadline
Immediately upon review; no specific deadline but non-compliance with invalid rules is no longer required.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Pharmaceutical Research & Manufacturers of America v. John McCuskey
- FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
- Bridging the Gap: Maine’s New Law Empowers Pharmacies and Pharmacists to Improve Rural Access to Medications - Buchanan Ingersoll & Rooney PC
- Decision and Order: Kerri Zavota, DVM
- Decision and Order: Gene M. Koop, DDS